Shop
(Box) Wondfo Pregnancy hCG Urine Test Cassette CLIA Waived, 25/Bx
SKU:
BB-PT01
The HCG Urine Test is a rapid pregnancy test, which you can easily carry out yourself. It detects the presence of human chorionic gonadotropin ("HCG"), which appears in urine very early during pregnancy.
The hCG series professional pregnancy cassette with pipettes tests are the preferred clinical brand for early detection of hCG (Human Chorionic Gonadotropin) in specimens. This test kit is used to obtain a visual, qualitative result for early detection of pregnancy. The pregnancy test cassette kit is for use in the monitoring of"early pregnancy"(6-15 days after egg fertilization).
Early pregnancy tests work by detecting the increase in human Chorionic Gonadotropin (hCG) hormone in urine that starts to develop after the fertilization of the egg (ovum). HCG rapidly starts to increase at exponential levels (see Pregnancy hCG development table).
(Box) CorDx COVID-19 Antigen At-Home OTC, 8 Test/ Bx
SKU:
BB-DX03
(Box) Wondfo Urine Drug Screen Cup CLIA Waived 12 Panel, 25/Bx
SKU:
BB-UD01
12-Panel T-Cup Compact; AMP, BAR, BUP, BZO, COC, mAMP, MDMA, MOP, MTD, OXY, PCP, THC
12-Panel Drug Test is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
®T-Cup Compact Multi-Drug Urine Test Cup offers any combinations from 2 to 15 drugs of abuse tests but only one cutoff concentration under same drug condition will be included per device. It is intended for over the-counter and for prescription use.
For in vitro diagnostic use.
(Box) Wondfo Pregnancy (10miu) – HCG Early Result strips, 25 tests/ Box
SKU:
BB-PS03
(Box) CorDx COVID-19 Antigen At-Home OTC, 2 Test/ Bx
SKU:
BB-DX01
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The CorDx COVID-19 Ag Test does not differentiate between SARS-CoV and SARS-CoV-2.
Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen, which is generally detectable in anterior nasal (nares) swab specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Individuals who test positive with the CorDx COVID-19 Ag Test should self-isolate and seek follow-up care with their physician or healthcare provider as additional testing may be necessary.